How many insider declarations has Lanza Frank J filed?

Lanza Frank J has filed 3 public insider declarations with SEC (Form 4).

What is Lanza Frank J's role?

Lanza Frank J's reported role is not specified by the regulator across the filings.

Which companies does Lanza Frank J report trades for?

Lanza Frank J reports trades for Harpoon Therapeutics, Inc..

← Executives ★ Sign in to follow

LF

Lanza Frank J

·SEC (Form 4)

Harpoon Therapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the complete record of transactions filed by Lanza Frank J. Officer active across 1 company, notably Harpoon Therapeutics, Inc.. Cumulatively, 3 filings have been logged. History available since 26 November 2023. The latest transaction was disclosed on 7 January 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.

Companies and markets linked to Lanza Frank J

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Harpoon Therapeutics, Inc. (US)

申报3 总计

●

Lanza Frank J

Principal Fin. & Acctng Ofc.高管2024年3月11日Harpoon Therapeutics, Inc.

0SEC ↗

18,734 股Common StockSEC:0000950170-24-029431:0

◆

Lanza Frank J

Principal Fin. & Acctng Ofc.高管2024年1月7日Harpoon Therapeutics, Inc.

0SEC ↗

15,000 股0Common StockSEC:0000950170-24-003367:0

◆

Lanza Frank J

Principal Fin. & Acctng Ofc.高管2023年11月26日Harpoon Therapeutics, Inc.

0SEC ↗

2,000 股0Common StockSEC:0001209191-23-056808:0

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

LF

Lanza Frank J

·SEC (Form 4)

Harpoon Therapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the complete record of transactions filed by Lanza Frank J. Officer active across 1 company, notably Harpoon Therapeutics, Inc.. Cumulatively, 3 filings have been logged. History available since 26 November 2023. The latest transaction was disclosed on 7 January 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.